Kadcyla Not Better Than Stndard 1st Tx, but Causes Fewer Effects

Options
Moderators
Moderators Member Posts: 25,912
edited January 2017 in Stage IV/Metastatic Breast Cancer ONLY

Kadcyla Not Better Than Standard of Care as First Treatment for Advanced-Stage, HER2-Positive Disease, but Causes Fewer Side Effects
January 20, 2016
Kadcyla wasn't more effective than Herceptin plus a taxane chemotherapy as the first treatment for advanced-stage, HER2-positive breast cancer, but offered women better quality of life. Read more...

· Share on FacebookShare on Twitter

Comments

Categories